Welcome to the Translational Glycomics Center at Versiti's Blood Research Institute in Milwaukee, Wisconsin. Our center is dedicated to advancing glycan-based research and bringing glycoscience to the forefront of medical research. We are proud to be at the forefront of glycoscience research and to be working towards a better understanding of the role of glycans in health and disease. We invite you to explore our website and learn more about our research, our team, and our mission to advance the field of glycoscience.

Who we are:

Our team of expert scientists and researchers uses a wide range of techniques and technologies to study glycans, including mass spectrometry, glycan microarray analysis, and glycan sequencing. We also work closely with clinicians and industry partners to translate our research into effective treatments for patients.

About Us »

What we do:

At the Translational Glycomics Center, we are committed to advancing the field of glycoscience through cutting-edge research and collaboration with leading scientists and institutions. Our research focuses on the development of glycan-based therapies for a variety of diseases, including cancer, bleeding disorders, and infectious diseases.

See All Services »

What are glycans?

Glycans are complex molecules found on the surface of cells and play a critical role in cell-to-cell communication. Glycans are involved in a wide range of biological processes, including inflammation, immunity, and cancer. As such, the study of glycans has the potential to revolutionize our understanding of disease and lead to the development of new therapies.

See Our Publications »

Our Vision:

We envision a future where the Translational Glycomics Center stands as a global leader in glycomics, pioneering breakthroughs that translate the intricate code of glycans into life-saving, personalized treatments for a wide range of diseases.

Our Mission:

The Translational Glycomics Center is dedicated to deciphering the language of glycans, empowering researchers to unlock their therapeutic potential and transform human health through the development of novel and personalized glycan-based therapies.